U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07058805) titled 'Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer' on June 22.
Brief Summary: COMPORT is a multicenter phase II clinical trial evaluating a personalized approach to postoperative radiotherapy in patients with head and neck squamous cell carcinoma (HNSCC). The study investigates whether a risk-adapted, compartmentalized radiotherapy strategy can safely reduce the treatment volume, and thus the side effects, without increasing the risk of tumor recurrence. Eligible patients are those with surgically treated cancers of the oral cavity, oropharynx, larynx, or hypopharynx who have a standard indication for postoperativ...